Fuwai Hospital, National Center for Cardiovascular Diseases | China
Author Profile
Scopus
Orcid ID
HENG ZHANG, M.D., PH.D. 🩺🫀
Dr. Heng Zhang is a distinguished medical professional specializing in cardiovascular surgery, with substantial contributions to the field of cardiovascular disease research, clinical practice, and health innovation. Holding a dual degree in medicine (M.D.) and a doctorate in philosophy (Ph.D.), Dr. Zhang’s academic and professional endeavors continue to shape the landscape of modern cardiovascular surgery, offering valuable insights into risk prediction, coronary revascularization, and the optimization of treatment strategies for cardiovascular diseases. His current role as an Associate Chief Physician at Fuwai Hospital, National Clinical Research Center of Cardiovascular Diseases, further cements his impact on the advancement of medical science.
EARLY ACADEMIC PURSUITS 🎓
Dr. Heng Zhang's academic journey began with an M.D. degree from Tianjin Medical University, where he graduated in 2010. During his studies, Dr. Zhang displayed a keen interest in cardiovascular health, which led him to pursue a Ph.D. in Cardiovascular Disease from Peking Union Medical College in 2015. Throughout his academic path, he also participated in key research exchanges, including a Visiting Scholar program in the USA at Duke Clinical Research Institute, further broadening his expertise in cardiovascular outcomes research and clinical performance measures.
PROFESSIONAL ENDEAVORS 👨⚕️🏥
Dr. Zhang’s clinical training began in 2009 with an internship at Nankai Hospital and continued through various stages of residency, including Peking Union Medical College Hospital and Fuwai Hospital. By 2015, he began specializing in cardiovascular surgery, eventually becoming an Attending Physician at Fuwai Hospital in 2019. His extensive clinical exposure includes pediatric and adult cardiac surgery, where he gained invaluable experience in treating complex heart conditions and improving patient outcomes through innovative surgical techniques.
CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOLOGY🔬💡
Dr. Zhang’s research has primarily focused on cardiovascular surgery registry, coronary revascularization risk prediction, and optimizing diagnostic and treatment strategies for cardiovascular conditions. He is deeply engaged in cardiovascular outcomes research, with particular attention to improving clinical performance measures and treatment protocols for heart diseases.
As the principal investigator and host of multiple high-impact research projects, Dr. Zhang has led groundbreaking studies such as evaluating the efficacy and safety of RN medications in preventing myocardial injury caused by ischemia-reperfusion and examining macrophage subtypes in coronary atherosclerosis. He has also significantly contributed to understanding valve replacement surgery and the long-term effects of heart valve interventions.
IMPACT AND INFLUENCE 🌍💪
Dr. Zhang's contributions to cardiovascular medicine have left a profound mark on clinical practice and research. Through his involvement in various research grants, including National Key Research and Development Plans of China and the Natural Science Foundation of China, Dr. Zhang has been pivotal in advancing both the theoretical and practical aspects of cardiovascular disease treatment and prevention. His work has also led to a shift in how cardiovascular surgeries are approached, particularly regarding patient-specific interventions in coronary artery malformation and atrial fibrillation.
His research projects have earned him several prestigious accolades, such as the Outstanding Reviewer for the Chinese Clinical Journal of Thoracic and Cardiovascular Surgery and the American Heart Association Travel Stipend Award. Dr. Zhang’s clinical and academic contributions are shaping future medical protocols, paving the way for a more personalized approach to heart disease treatment.
ACADEMIC CITES & HONORS 🏅📚
Dr. Zhang’s academic excellence is reflected not only in his research citations but also in the numerous honors and scholarships he has received. These include multiple first prizes for Young Investigator Awards, outstanding doctoral dissertations, and recognitions for clinical excellence. His impressive list of awards, including the Beijing Science and Technology Award (2016) and the Outstanding Doctoral Dissertation from Peking Union Medical College (2016), highlights his leadership and commitment to medical innovation.
LEGACY AND FUTURE CONTRIBUTIONS 🔮🏅
Dr. Zhang’s legacy lies in his consistent drive to innovate and advance cardiovascular surgery. His work with various research institutions and medical centers has laid a robust foundation for the continued improvement of heart disease diagnosis and treatment. As a principal investigator for several key projects and his role on editorial boards such as the Journal of American Heart Association, Dr. Zhang is poised to influence future cardiovascular research and practice for years to come.
Looking ahead, his research into heart valve replacement and atrial fibrillation is expected to lead to new clinical strategies that will enhance patient care globally. His future contributions are expected to redefine approaches to cardiovascular health, with an emphasis on personalized medicine and novel surgical techniques.
FINAL THOUGHTS 🧠💖
Dr. Heng Zhang is a leading figure in cardiovascular medicine, combining clinical expertise with cutting-edge research to make significant advancements in heart disease treatment. His future is one of continued excellence and innovation, as he works tirelessly to shape the future of cardiovascular care, improving the lives of patients worldwide.
NOTABLE PUBLICATIONS 📑
"Impact of remnant cholesterol on short-term and long-term prognosis in patients with prediabetes or diabetes undergoing coronary artery bypass grafting: a large-scale cohort study"
- Authors: Z., Li, Zhongchen , C., Yu, Chunyu , H., Zhang, Heng , Y., Zhao, Yan , Z., Zheng, Zhe
- Journal: Cardiovascular Diabetology
- Year: 2025
"Association of stress hyperglycemia ratio with short-term and long-term prognosis in patients undergoing coronary artery bypass grafting across different glucose metabolism states: a large-scale cohort study"
- Authors: Z., Li, Zhongchen , R., Chen, Runze , Z., Zeng, Zhiwei , H., Zhang, Heng , Z., Zheng, Zhe
- Journal: Cardiovascular Diabetology
- Year: 2025
"Clinical Outcomes of Surgical Revascularization Strategies Guided by Quantitative Flow Ratio in Primary Noncoronary Cardiac Surgery"
- Authors: L., Li, Linlin , H., Zhang, Heng , C., Rao, Chenfei , C., Liu, Chang , H., Fan, Hongguang
- Journal: Journal of Thoracic Imaging
- Year: 2024
"Association of carotid duplex ultrasonography screening with stroke and mortality among patients undergoing coronary artery bypass grafting"
- Authors: H., Zhang, Heng , D., Zhang, Danwei , J., Qu, Jianyu , X., Qian, Xiangyang , Z., Zheng, Zhe
- Journal: Journal of Vascular Surgery
- Year: 2024
"Impact of High Lipoprotein(a) on Long-Term Survival Following Coronary Artery Bypass Grafting"
- Authors: S., Yuan, Shuo , F., Li, Fangzhou , H., Zhang, Heng , Y., Zhao, Yan , Z., Zheng, Zhe
- Journal: Journal of the American Heart Association
- Year: 2024